HOME › DRUGS › BEMPEDOIC ACID
ACTIVE SUBSTANCE / INN

BEMPEDOIC ACID

Brand name(s): NEXLETOL, NEXLIZET, Nilemdo
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA211616
Hypercholesterolemia;Dyslipidemias
ACTIVE SUBSTANCE
Bempedoic Acid
REGULATORS
FDA · EMA
SPONSORS / MAH
ESPERION THERAPS INC, Daiichi Sankyo Europe GmbH
TOTAL APPLICATIONS
3
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
NEXLIZETNDA211617ESPERION THERAPS INCPrescription
NEXLETOLNDA211616ESPERION THERAPS INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NilemdoDaiichi Sankyo Europe GmbHAuthorised01/04/2020Hypercholesterolemia;Dyslipidemias

FULL INTELLIGENCE ON BEMPEDOIC ACID

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →